CLINICAL_TRIALS ClinicalTrials.gov record update

Response Evaluation of Peginterferon Alfa-2a 180µg 20kDa (Unipeg®) Plus Ribavirin (Ribazole®) in Treatment naïve Pakistani Population With Chronic Hepatitis C Infection

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02601976
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:08.393086+00:00
Published At: 2018-09-27T00:00:00+00:00
Record Updated At: 2018-09-27
Results Posted At: 2018-09-27
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hepatitis C"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-09-27"
protocolSection.identificationModule.nctId: "NCT02601976"
protocolSection.identificationModule.officialTitle: "Response Evaluation of Peginterferon Alfa-2a 180\u00b5g 20kDa (Unipeg\u00ae) Plus Ribavirin (Ribazole\u00ae) in Treatment na\u00efve Pakistani Population With Chronic Hepatitis C Infection"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2018-09-27"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.